Premium
Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies
Author(s) -
Napolitano M.,
Di Minno M. N. D.,
Batorova A.,
Dolce A.,
GiansilyBlaizot M.,
Ingerslev J.,
Schved J.F.,
Auerswald G.,
Kenet G.,
Karimi M.,
Shamsi T.,
Ruiz de Sáez A.,
Dolatkhah R.,
Chuansumrit A.,
Bertrand M. A.,
Mariani G.
Publication year - 2016
Publication title -
haemophilia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.213
H-Index - 92
eISSN - 1365-2516
pISSN - 1351-8216
DOI - 10.1111/hae.12978
Subject(s) - medicine , mucocutaneous zone , incidence (geometry) , pediatrics , cohort , factor vii , gynecology , surgery , coagulation , disease , physics , optics
A paucity of data exists on the incidence, diagnosis and treatment of bleeding in women with inherited factor VII ( FVII ) deficiency. Aim Here we report results of a comprehensive analysis from two international registries of patients with inherited FVII deficiency, depicting the clinical picture of this disorder in women and describing any gender‐related differences. Methods A comprehensive analysis of two fully compatible, international registries of patients with inherited FVII deficiency (International Registry of Factor VII deficiency, IRF 7; Seven Treatment Evaluation Registry, STER ) was performed. Results In our cohort ( N = 449; 215 male, 234 female), the higher prevalence of mucocutaneous bleeds in females strongly predicted ensuing gynaecological bleeding (hazard ratio = 12.8, 95% CI 1.68–97.6, P = 0.014). Menorrhagia was the most prevalent type of bleeding (46.4% of patients), and was the presentation symptom in 12% of cases. Replacement therapies administered were also analysed. For surgical procedures ( n = 50), a receiver operator characteristic analysis showed that the minimal first dose of rFVII a to avoid postsurgical bleeding during the first 24 hours was 22 μg kg −1 , and no less than two administrations. Prophylaxis was reported in 25 women with excellent or effective outcomes when performed with a total weekly rFVII a dose of 90 μg kg −1 (divided as three doses). Conclusion Women with FVII deficiency have a bleeding disorder mainly characterized by mucocutaneous bleeds, which predicts an increased risk of ensuing gynaecological bleeding. Systematic replacement therapy or long‐term prophylaxis with rFVII a may reduce the impact of menorrhagia on the reproductive system, iron loss and may avoid unnecessary hysterectomies.